deltatrials
Not Yet Recruiting PHASE2 INTERVENTIONAL 5-arm NCT03435718

Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults

An Assessor Blind, Randomized, Comparative Study of the Efficacy of Different Doses of Oxfendazole Compared to Single Dose Albendazole in the Treatment of Trichuris Trichiura Infection in Adults

Sponsor: Oxfendazole Development Group

Updated 10 times since 2018 Last updated: Nov 7, 2023 Started: Jul 31, 2024 Primary completion: Jul 31, 2026 Completion: Oct 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Trichuris Infection, this trial is actively recruiting participants. The trial is conducted by Oxfendazole Development Group and has accumulated 10 data snapshots since 2024. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotNot Yet Recruiting~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshotNot Yet Recruiting~Apr 2019 – ~Oct 2020 · 18 months · monthly snapshotNot Yet Recruiting~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotNot Yet Recruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotNot Yet Recruiting~Oct 2021 – ~Sep 2022 · 11 months · monthly snapshotNot Yet Recruiting~Sep 2022 – ~Dec 2023 · 15 months · monthly snapshotNot Yet Recruiting~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotNot Yet Recruiting~Sep 2024 – present · 22 months · monthly snapshotNot Yet Recruiting

Change History

10 versions recorded
  1. Sep 2024 — Present [monthly]

    Not Yet Recruiting PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting PHASE2

  3. Dec 2023 — Jul 2024 [monthly]

    Not Yet Recruiting PHASE2

  4. Sep 2022 — Dec 2023 [monthly]

    Not Yet Recruiting PHASE2

  5. Oct 2021 — Sep 2022 [monthly]

    Not Yet Recruiting PHASE2

Show 5 earlier versions
  1. Jan 2021 — Oct 2021 [monthly]

    Not Yet Recruiting PHASE2

  2. Oct 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE2

  3. Apr 2019 — Oct 2020 [monthly]

    Not Yet Recruiting PHASE2

  4. Jun 2018 — Apr 2019 [monthly]

    Not Yet Recruiting PHASE2

  5. Mar 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Oxfendazole Development Group
  • Universidad Peruana Cayetano Heredia, Lima, Peru
Data source: Oxfendazole Development Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.